Yoshihiko Yano Selected Research

Reagins

11/2022

Comparison of 17 serological treponemal and nontreponemal assays for syphilis: A retrospective cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshihiko Yano Research Topics

Disease

33	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 01/2002
25	Infections 01/2020 - 01/2004
15	Chronic Hepatitis B 01/2020 - 05/2004
11	Neoplasms (Cancer) 02/2024 - 04/2002
11	Liver Diseases (Liver Disease) 06/2019 - 01/2003
10	Chronic Hepatitis C 01/2017 - 01/2002
9	Fibrosis (Cirrhosis) 04/2024 - 01/2004
9	Hepatitis B 01/2021 - 07/2005
6	Chronic Hepatitis (Chronic Active Hepatitis) 01/2017 - 01/2002
6	Hepatitis 09/2016 - 03/2004
4	Non-alcoholic Fatty Liver Disease 10/2022 - 07/2012
3	Liver Cirrhosis (Hepatic Cirrhosis) 10/2020 - 04/2012
3	Virus Diseases (Viral Diseases) 09/2016 - 04/2013
2	Hemorrhage 01/2024 - 01/2007
2	Viremia 01/2021 - 01/2003
2	Disease Progression 01/2016 - 07/2013
2	Hepatitis A (Hepatitis, Infectious) 10/2014 - 04/2013
2	Thrombosis (Thrombus) 11/2013 - 01/2007
2	Liver Neoplasms (Liver Cancer) 01/2013 - 01/2012
2	Inflammation (Inflammations) 07/2012 - 03/2004
2	Carcinoma (Carcinomatosis) 04/2004 - 11/2003
1	Pancytopenia 04/2024
1	Hepatic Insufficiency 04/2024
1	Polyploidy 10/2023
1	Chromosome Duplication 10/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2023
1	Birth Weight (Birth Weights) 03/2023
1	Hypothyroidism 01/2023
1	Syphilis 11/2022
1	Obesity 05/2022
1	Sarcopenia 11/2021
1	Liver Cell Adenoma (Hepatocellular Adenoma) 06/2021
1	Liver Failure 06/2021
1	Melanoma (Melanoma, Malignant) 06/2021
1	Acute-On-Chronic Liver Failure 06/2021
1	Suppuration 02/2021
1	Liver Abscess 02/2021

Drug/Important Bio-Agent (IBA)

16	InterferonsIBA 11/2019 - 01/2002
10	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2018 - 07/2010
9	Proteins (Proteins, Gene)FDA Link 06/2019 - 04/2002
8	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2003
8	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 01/2012
7	Antiviral Agents (Antivirals)IBA 01/2020 - 08/2005
6	lenvatinibIBA 03/2023 - 10/2020
6	Hepatitis B e AntigensIBA 10/2014 - 01/2003
5	AntigensIBA 01/2021 - 10/2014
4	Bevacizumab (Avastin)FDA Link 02/2024 - 03/2022
4	atezolizumabIBA 02/2024 - 03/2022
4	Surface Antigens (Surface Antigen)IBA 10/2015 - 07/2005
4	Alanine Transaminase (SGPT)IBA 04/2013 - 07/2005
3	Biomarkers (Surrogate Marker)IBA 10/2023 - 06/2013
3	Tumor Biomarkers (Tumor Markers)IBA 09/2023 - 11/2003
3	RNA (Ribonucleic Acid)IBA 01/2017 - 01/2002
3	GadoliniumIBA 10/2015 - 05/2011
3	Indicators and Reagents (Reagents)IBA 08/2015 - 06/2006
3	Interferon-alpha (Interferon Alfa)IBA 08/2005 - 01/2004
2	RamucirumabIBA 05/2024 - 09/2021
2	acarboxyprothrombin (PIVKA)IBA 01/2024 - 01/2013
2	Tyrosine Kinase InhibitorsIBA 03/2023 - 06/2022
2	AcidsIBA 06/2021 - 03/2017
2	Small Interfering RNA (siRNA)IBA 01/2019 - 12/2010
2	HLA-DP Antigens (HLA-DP)IBA 10/2017 - 01/2016
2	SofosbuvirIBA 01/2017 - 01/2016
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2017 - 01/2015
2	gadolinium ethoxybenzyl DTPA FDA Link 10/2015 - 05/2011
2	Pentetic Acid (DTPA)FDA LinkGeneric 10/2015 - 01/2012
2	telaprevirIBA 01/2015 - 06/2014
2	Immunoglobulin M (IgM)IBA 10/2014 - 04/2013
2	Prothrombin (Factor II)IBA 10/2012 - 01/2012
2	diethylenetriamineIBA 01/2012 - 05/2011
2	Acetic Acid (Vinegar)FDA LinkGeneric 05/2011 - 04/2002
2	nucleotide pyrophosphataseIBA 04/2004 - 11/2003
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 04/2004 - 11/2003
1	EnzymesIBA 04/2024
1	Ubiquitin-Conjugating EnzymesIBA 10/2023
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2023
1	squamous cell carcinoma-related antigenIBA 09/2023
1	CreatinineIBA 03/2023
1	Thyroid HormonesIBA 01/2023
1	ReaginsIBA 11/2022
1	Ribosomal DNA (rDNA)IBA 10/2022
1	Sorafenib (BAY 43-9006)FDA Link 06/2022
1	Resistant StarchIBA 05/2022
1	Immune Checkpoint InhibitorsIBA 06/2021
1	NivolumabIBA 06/2021
1	BilirubinIBA 06/2021
1	IpilimumabIBA 06/2021
1	CateninsIBA 06/2021
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 06/2021
1	beta CateninIBA 06/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2021

Therapy/Procedure

28	Therapeutics 05/2024 - 01/2002
5	Aftercare (After-Treatment) 02/2024 - 01/2007
4	Renal Dialysis (Hemodialysis) 09/2016 - 08/2013
3	Transplantation 04/2024 - 10/2015
2	Hepatectomy 11/2021 - 03/2004
2	Liver Transplantation 06/2021 - 10/2015
1	Kidney Transplantation 04/2024
1	Molecular Targeted Therapy 06/2022
1	Punctures 02/2021